background image
team includes Gad Getz, PhD, who
directs the Cancer Genome Compu-
tational Analysis group--considered
a world leader in next-generation se-
quencing for analyzing cancer muta-
tions--at the Broad Institute of MIT
and Harvard.
Dr. Giordano's findings suggest that
papillary thyroid carcinoma is geneti-
cally heterogeneous, opening the door
to a potentially more meaningful clas-
sification of thyroid cancer. His ulti-
mate goal is to catalyze the discussion
about the classification of thyroid
tumors, possibly avoiding thyroidec-
tomies for benign disease and, overall,
more precisely matching therapy with
tumor biology.
When he isn't in the laboratory or
presenting his findings to the nation
and the world, Dr. Giordano resides in
Ann Arbor, Michigan, with his wife,
New Jersey native Georgette David, a
graduate of Seton Hall and Villanova
Law School, and three children: Luke,
18, Ethan, 16, and Jillian, 11.
Robert Wood Johnson
he opportunity to train in
the combined MD/PhD
program at Robert Wood
Johnson Medical School
and Rutgers provided the
foundation for the rest of my
career and opened the door
to train in anatomic pathology
at the National Institutes of
Health (NIH)."
--Thomas J. Giordano, MD '90, PhD